ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633271; 2) Community: the network communities that were significantly associated with the response to NSC 633271; 3) Molecule: the relationships between components within communities and NSC 633271; 4) MDR: the compounds that were significantly associated with the NSC 633271.

NSC Compound Enrichment Correlation
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.0348927754043159 -0.077982194
NSC 126849 DeazaUrd 0.0352383000003052 0.26103693
NSC 343499 CI-921: amsacrine derivative 0.0352383000003052 -0.05671822
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.0352383000003052 0.40843017
NSC 364830 Camptothecin Derivative 0.0352383000003052 -0.0019855229
NSC 372364 Null 0.0352383000003052 -0.11481456
NSC 409304 Null 0.0352383000003052 -0.1301308
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0352383000003052 0.53002052
NSC 624153 Null 0.0352383000003052 0.32028181
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0352383000003056 0.42082645
Total:75  Current:52    [First] [Prev] [Next] [Last]